The Fragile X Protein binds mRNAs involved in cancer progression and modulates metastasis formation
Version of Record online: 2 APR 2014
© 2014 The Authors.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
EMBO Molecular Medicine
Volume 6, Issue 4, pages 567–568, April 2014
How to Cite
Correction to: EMBO Mol Med (2013) 5, 1523–1536. DOI: 10.1002/emmm.201302847
- Issue online: 2 APR 2014
- Version of Record online: 2 APR 2014
Vol. 5, Issue 10, 1523–1536, Version of Record online: 16 SEP 2013
The authors of the above research article regret two oversights.
First, one of the affiliations of the corresponding author, Claudia Bagni, was incorrect. The affiliations should read as 1, 2, 4 (see below).
- (1)VIB Center for the Biology of Disease, Leuven, Belgium
- (2)Center for Human Genetics, KU Leuven, Belgium
- (4)Department of Biomedicine and Prevention, University “Tor Vergata”, Rome, Italy
Second, the control image for Vimentin shown in Fig 4B should be replaced by the one presented here.
The results and conclusions of the article remain unchanged.